Tag: Cardiol Therapeutics Inc.
July 25, 2019
Cardiol Therapeutics to Present at Canaccord Genuity 39th Annual Growth Conference
Cardiol Therapeutics Inc. (TSX:CRDL, OTCQX:CRTPF) ("Cardiol" or the "Company"), focused on producing pharmaceutical CBD products and developing innovative therapies for...
June 20, 2019
Cardiol Therapeutics Announces Plans for Orphan Drug Program in Acute Myocarditis with CardiolRx CBD Formulation
Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) ("Cardiol" or the "Company") is pleased to announce that the Company is planning...
June 10, 2019
Cardiol Therapeutics to Webcast Annual General Meeting on June 12
Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) ("Cardiol" or the "Company"), a leader in the research and commercial development of pharmaceutical... June 3, 2019
Cardiol Therapeutics’ Pharmaceutical Partner Noramco Presents at U.S. FDA Public Hearing on CBD
Cardiol Therapeutics Inc. (TSX:CRDL, OTCQX:CRTPF) ("Cardiol" or the "Company"), a leader in the research and commercial development of pharmaceutical cannabidiol (CBD)... May 30, 2019
Cardiol Therapeutics Commences Trading on the OTCQX
Cardiol Therapeutics Inc. (TSX:CRDL) (OTCQX: CRTPF) ("Cardiol" or the "Company"), a leader in the research and commercial development of pharmaceutical... April 30, 2019
Cardiol is a Leader in Pharmaceutically Pure CBD
Cardiol Therapeutics Inc. (TSX:CRDL,OTC:CRTPF) was featured in an article by Technical420 which covered the shift away from cannabis cultivation into a... March 28, 2019